Please login to the form below

Not currently logged in
Email:
Password:

Prix Galien

This page shows the latest Prix Galien news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts. Seven treatments for rare conditions have been selected for the final. ... The shortlist was drawn up by the UK Prix Galien’s independent panel of distinguished physicians, chaired by

Latest news

  • Prix Galien opens for entries with new award Prix Galien opens for entries with new award

    Prix Galien opens for entries with new award. 2018 programme will include new medical technology category. ... Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Bexero, Cervarix and Gardasil.

  • NICE backs Europe's first stem cell therapy NICE backs Europe's first stem cell therapy

    Holoclar - which won the UK Prix Galien award in 2016 - is the first product from Chiesi's nine-year-old rare disease unit to reach the market, although it could shortly

  • Chiesi's Holoclar wins UK Prix Galien orphan drug award Chiesi's Holoclar wins UK Prix Galien orphan drug award

    Chiesi's Holoclar wins UK Prix Galien orphan drug award. Novartis and Astellas also scoop prizes at the prestigious ceremony. ... It marks the fourth UK Prix Galien for the company since 2002 and its second successive Innovative Product Award, after

  • AZ, BMS and Boehringer among UK Prix Galien finalists AZ, BMS and Boehringer among UK Prix Galien finalists

    AZ, BMS and Boehringer among UK Prix Galien finalists. They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda. ... Novartis awarded 2014 UK Prix Galien for Bexser. AstraZeneca, Bristol-Myers Squibb and Boehringer Ingelheim are among the

  • Pharma could make more of its real world evidence Pharma could make more of its real world evidence

    In 2016, the category is open to medicines that have won or received a commendation at previous UK Prix Galien Awards. ... The introduction of the Real World Evidence Award is an important milestone in the evolution of UK Prix Galien.

More from news
Approximately 7 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • The world is our laboratory The world is our laboratory

    We developed Sirturo (bedaquiline), the first new medicine for tuberculosis in 40 years, which received the UK Prix Galien Award for most innovative orphan drug in October 2014.

  • Interview: Cesar Rodriguez, Janssen Interview: Cesar Rodriguez, Janssen

    Rodriguez also references infectious diseases as a stronghold for the company, mentioning the victory for hepatitis C treatment telaprevir in the 2012 UK Prix Galien Innovative Product Award.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics